Brought to you by 
Pozen and Tribute combine to form Aralez Pharmaceuticals
Jun 2015
Executive Summary
US biotech Pozen Inc. paid $146mm to acquire public Canadian company Tribute Pharmaceuticals Canada Inc., forming Aralez Pharmaceuticals PLC, which will trade on Nasdaq and TSX and be domiciled in Ireland.
Deal Industry
-
Biotechnology
- Large Molecule
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Cash
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pozen and Tribute combine to form Aralez Pharmaceuticals
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice